NCT01350154View on ClinicalTrials.gov

Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Becker Muscular Dystrophy
Interventions
DRUG

Sildenafil

20 mg in gelatine capsules, oral, three times daily

DRUG

Placebo

Lactose monohydrate oral in gelatine capsules, 3 times daily

Trial Locations (1)

2100

Neuromuscular Clinic and Research Unit, Dept. Neurology, Rigshospitalet,, Copenhagen

All Listed Sponsors
collaborator

Glostrup University Hospital, Copenhagen

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT01350154 - Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients | Biotech Hunter | Biotech Hunter